HKG Equity Snapshot

1801 Weekly Equity Report

Innovent Biologics, Inc.

Interactive chart JSON snapshot

Latest Close 76.45 HKD 12 Jun 2026

1W Return -0.2% latest completed week

4W Return -6.8% short-term follow-through

12W Return -5.7% quarterly tape

Trend Breadth 51.9% 27 of 52 weeks active

Volume Ratio 1.3x vs 13-week average

Company Brief

What the company does

Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 …

Snapshot

What the weekly tape is saying

1801 closed the latest completed week at 76.45 HKD. The 4-week return is -6.8% and the 12-week return is -5.7%. Trend Signal is inactive, Market Dynamics is -0.60. Setup signature: Risk-first tape with a 27/100 composite read.

Trend Signal Inactive

Market Dynamics No fresh buy

Price vs Trend -10.3%

Volume 1.3x

Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

27 Risk-first tape

Scoreboard

Trend 29 Persistence of active Trend Signal over the last year and current streak.

Momentum 29 Blend of 4-week and 12-week follow-through.

Dynamics 16 Latest Market Dynamics and whether pressure has improved over four weeks.

Relative Strength 20 Relative leadership and short-term RS change.

Volume 53 Participation compared with the 13-week volume baseline.

Risk Control 14 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun

Weekly return bar Trend Signal dot Positive Market Dynamics dot

Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line: 85.21 HKD
Vs Trend Line: -10.3%
Fair Value: 56.32 HKD
Vs Fair Value: 35.7%
52W High: 109.1 HKD
52W Low: 69.55 HKD
Drawdown: -29.9%
Range Position: 17.4%

Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -0.2%

4W -6.8%

12W -5.7%

26W -10.3%

52W -5.3%

Trend read

Active Streak: 0 weeks
52W Active Weeks: 27
52W Active Breadth: 51.9%
Sector Scope: HK Healthcare
Sector Rank: 102 of 257
Sector Percentile: 60.5%

Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

HK Healthcare

Tracked Peers: 100
4W Rank: 28 of 100
Avg 1W: -1.3%
Avg 4W: -12.8%
Trend Breadth: 6.0%
Positive MD: 10.0%

2526 · HKG 8.3% 2506 · HKG 7.9% 3600 · HKG 4.9% 1513 · HKG 0.6% 2172 · HKG 0.3%

HK Biotechnology

Tracked Peers: 76
4W Rank: 14 of 76
Avg 1W: -1.6%
Avg 4W: -17.5%
Trend Breadth: 3.9%
Positive RS: 5.3%

1521 · HKG 10.1% 6622 · HKG 7.5% 3880 · HKG 4.1% 1541 · HKG 2.6% 1244 · HKG 0.0%

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics: -0.60
4W MD Change: -287.2%
Relative Strength: -9.16
4W RS Change: -36.9%
Expectation: Undecided
Probability: 51.62%

Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume: 76.6M
13W Average: 61.1M
52W Average: 74.1M
Vs 13W: 1.3x
Vs 52W: 1.0x

Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility: 4.9%
52W Volatility: 5.5%
Upside Weeks: 22
Downside Weeks: 29
Downside Breadth: 55.8%
Avg Gain / Loss: 5.3% / -4.0%

Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange: HKG
Country: HK
Sector: Healthcare
Industry: Biotechnology
Currency: HKD
Market Cap: 140.3B

Opportunity signals

Price is above Fair Value, showing premium demand versus the model.

Risk signals

Trend Signal is inactive, so price action has not confirmed a constructive regime.
Price is below the Trend Line, which keeps downside pressure in focus.
Market Dynamics is negative, which weakens the current setup.
The share remains more than 20% below its 52-week high.

Watch next

Trend Line remains the key weekly regime level.
Market Dynamics is the pressure gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week	Close	Return	Trend	Fair Value	MD	RS	Volume	Signal
12 Jun 2026	76.45 HKD	-0.2%	85.21 HKD	56.32 HKD	-0.60	-9.16	76.6M	Off
5 Jun 2026	76.60 HKD	-8.1%	85.73 HKD	56.07 HKD	-0.43	-10.02	72.7M	Off
29 May 2026	83.35 HKD	3.0%	86.02 HKD	55.82 HKD	-0.06	-2.95	77.8M	Off
22 May 2026	80.95 HKD	-1.3%	86.14 HKD	55.52 HKD	0.15	-6.96	65.4M	Off
15 May 2026	82.00 HKD	-8.9%	86.30 HKD	55.24 HKD	0.32	-6.69	64.2M	Off
8 May 2026	90.00 HKD	0.0%	86.46 HKD	54.96 HKD	0.53	1.30	51.4M	On
1 May 2026	90.00 HKD	4.9%	86.59 HKD	54.64 HKD	0.43	4.39	44.7M	Off
24 Apr 2026	85.80 HKD	-6.2%	86.86 HKD	54.32 HKD	0.53	-0.65	57.7M	Off
17 Apr 2026	91.50 HKD	3.4%	87.10 HKD	54.01 HKD	0.62	5.72	61.7M	Off
10 Apr 2026	88.50 HKD	-3.3%	87.12 HKD	53.68 HKD	0.33	4.08	36.9M	Off
3 Apr 2026	91.50 HKD	7.0%	87.43 HKD	53.38 HKD	0.10	11.68	70.5M	Off
27 Mar 2026	85.50 HKD	5.5%	87.82 HKD	53.04 HKD	-0.24	5.95	67.6M	Off
20 Mar 2026	81.05 HKD	0.2%	88.20 HKD	52.72 HKD	-0.40	0.01	47.5M	Off
13 Mar 2026	80.85 HKD	-2.9%	88.81 HKD	52.45 HKD	-0.38	-0.08	58.4M	Off